Pulse Biosciences Bought 15,000: What It Means for Investors
A notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
A financial planner can help you navigate retirement planning, ensuring you have the right strategies in place for a secure future.
25,466 articlesA notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
Oil trades around the $100 barrel mark as investors seek safety. This piece identifies a top defensive ETF and explai...
Pershing Square’s bill ackman been quietly building a Microsoft stake since February signals a patient, long-term bet...
As volatility tests investors, three utility ETFs offer steady income with defensive exposure. Here’s how XLU, VPU, a...
Deals eyes turn to a potential pact between the U.S. and Iran over Tehran's nuclear program, with a signing anticipat...
As volatility stays elevated, a hedge against rising option premiums is gaining attention. The 8%-yield S&P 500 Premi...
As stocks edge higher in mid-2026, a 64-year dividend king stands out as a pristine entry point for income-focused in...
Get a clear, investor-friendly view of Perion's 2025 earnings outlook. This guide explains revenue drivers, margins, ...
A viral Substack piece by a former EMT triggered rapid stock declines as AI fears spread. This article explains what ...
A teen performer eyeing big-stage gigs is making headlines. This piece breaks down Curtis Stone’s Hudson reportedly D...
Renew (rnw) just released its 2026 earnings, signaling momentum in project execution and cash flow. This article brea...
Vanguard’s mid-cap ETF VO is drawing renewed attention as markets tilt toward diversification beyond mega-cap tech. T...